Ignite Creation Date:
2025-12-24 @ 11:38 PM
Ignite Modification Date:
2026-01-01 @ 12:41 PM
Study NCT ID:
NCT03992456
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-05-21
First Post:
2019-06-18
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Panitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal Cancer
Sponsor:
Academic and Community Cancer Research United
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-04-24
Start Date Type:
ACTUAL
Primary Completion Date:
2023-12-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-10-07
Completion Date Type:
ESTIMATED
First Submit Date:
2019-06-18
First Submit QC Date:
None
Study First Post Date:
2019-06-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-12-13
Results First Submit QC Date:
None
Results First Post Date:
2024-05-21
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-16
Last Update Post Date:
2024-05-21
Last Update Post Date Type:
ACTUAL